A common flu virus could be used to overcome patients’ resistance to certain cancer drugs — and improve how those drugs kill cancer cells, according to new research from Queen Mary University of London (QMUL).
The work, funded by UK charity Pancreatic Cancer Research Fund, contributes to a growing area in cancer treatment in which viruses are harnessed to kill cancer cells.
Viruses can be modified to specifically infect cancer cells, and use them as a factory to generate thousands of new viruses, replicating until the cancer cell bursts. The virus copies will then spread and infect surrounding tumour cells and repeat the process, leaving healthy cells unharmed.
But the body’s immune system will usually kill off the virus before it is able to infect all the cells within a tumour. In pancreatic cancer, therefore, drugs such as gemcitabine are currently the most common treatment — they work by damaging the DNA in the cancer cells, so they are unable to divide successfully. This damage triggers a process called apoptosis, in which damaged or unhealthy cells are forced to self-destruct.
Over time, however, the cancer cell becomes able to delay apoptosis in order to repair the damage to its DNA, which means that the cells survive and continue to divide and spread and the drug becomes less effective.
In a study published in the journal Oncotarget, the team at QMUL’s Barts Cancer Institute introduced a genetic modification to the virus, called adenovirus, to give it an extra weapon against cancer cells.
By switching off a particular gene in the virus which counteracts apoptosis, the scientists found cancer cells studied in the laboratory were unable to delay apoptosis and so forced to die without dividing. The modified virus still infects some cancer cells and replicates until the cell bursts, but by also preventing the cancer cells from developing drug resistance, it works with the anti-cancer drug to increase the number of cells that are killed.
“Many cancers — including pancreatic cancer — become resistant to treatments like gemcitabine, and currently there’s no way to get round that,” explains Dr Gunnel Halldèn, who led the research. “The virus that we have modified re-sensitises the resistant cancer cell by preventing the cell from repairing itself. The virus alone will kill some tumour cells, but in combination with the drug, the number of cells that are killed is greatly increased.
“Because the virus improves the efficacy of the drug, it means it could also be possible to give lower doses, which will also reduce the unpleasant side-effects associated with chemotherapy,” she adds.
Developing virus-based cancer therapies has been a key goal in cancer research for several years and some technologies have already moved into the clinic: last year, for example, a melanoma therapy, based on a herpes virus called T-VEC, was approved for use in the US and in Europe.
The QMUL research is at an early stage, but the team believe they have found a promising new route for developing combination treatments for pancreatic cancer.
The next step for the researchers will be to test other modified versions of adenovirus to better understand the exact mechanism through which it enhances cell killing. Further modifications will also be made to enable the virus to trigger the body’s immune system, which will attack any cancer cells that have not been infected by the virus.
Learn more: Modified flu virus can ‘resensitize’ resistant pancreatic cancer cells to chemotherapy
The Latest on: Virus-based cancer therapies
[google_news title=”” keyword=”Virus-based cancer therapies” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Virus-based cancer therapies
- Cervical cancer deaths in Louisiana remain high, as parents decline HPV vaccine for teenson May 16, 2024 at 5:00 pm
In Australia, where a school-based vaccination program was started ... causing health problems in about two years. But when the virus sticks around, it can cause genital warts and cancer. HPV can also ...
- How Gene Editing Therapies Could Go Beyond Rare Diseaseson May 16, 2024 at 6:00 am
In the wake of the first CRISPR medicine, scientists are working to develop gene editing therapies for diseases like cystic fibrosis, ALS and cardiovascular disease.
- How to spot the signs and symptoms of throat canceron May 15, 2024 at 8:00 am
A lack of public awareness around throat cancer means only 13 per cent of head and neck cancers are currently diagnosed at an early stage. A fact that Chris Curtis, the founder of The Swallows Head ...
- Plant virus-based treatment effective against metastatic canceron May 14, 2024 at 7:25 am
In a recent study, researchers have developed an experimental treatment made from a plant virus that shows effectiveness in protecting against a broad range of metastatic cancers in mice ...
- CG Oncology Reports Bladder Cancer Treatmenton May 13, 2024 at 2:46 pm
A biomedical company, CG Oncology Inc., may be taking on industry giants Merck and Ferring Pharmaceuticals with a new way to treat bladder cancer.
- Plant virus based nanoparticles show promise against metastatic cancer in miceon May 12, 2024 at 5:00 pm
The treatment, composed of nanoparticles fashioned from the cowpea mosaic virus – a virus that infects black-eyed pea plants – showed remarkable success in improving survival rates and suppressing the ...
- Breakthrough therapies are saving lives. Can we afford them?on May 12, 2024 at 3:32 pm
Harnessing the body’s own cells to fight disease, long a medical dream, is finally a reality. Now comes the bill. Last month, Stanford became the first hospital in the nation to use a new $515,000 ...
- Mayo Clinic Q&A: Tonsil cancer: What is it and how do you prevent it?on May 12, 2024 at 7:14 am
The HPV vaccine has been available since 2006 in the U.S. It's FDA-approved for males and females ages 9 to 45. For cancer prevention, we know from studies that earlier is better, before sexual ...
- Oncolytic Viruses: A Promising New Option in Cancer Treatmenton May 8, 2024 at 7:59 am
As part of its Speaking Out video series, Targeted Oncology spoke with Howard D. Edington, MD, about the benefits of using oncolytic viruses in cancer treatment.
- Oncolytic Newcastle Disease Virus for Cancer Therapyon April 26, 2024 at 5:00 pm
The first documented use of NDV for human cancer therapy was ... targeting of the virus presents a challenge and could be achieved through the development of tissue culture-based systems for ...
via Bing News